Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lars Bolvig Hansen"'
Autor:
Kaj Døssing, MD, Inger Mechlenburg, PhD, Lars Bolvig Hansen, MD, Kjeld Søballe, DMSc, Helle Østergaard, MSc
Publikováno v:
JBJS Open Access, Vol 2, Iss 3, p e0007 (2017)
Background:. The purpose of the present study was to investigate whether ultrasonography can be used as a diagnostic tool to exclude extremity fractures in adults. Methods:. This prospective comparative study involved 91 patients (age, ≥18 years) w
Externí odkaz:
https://doaj.org/article/3bbd0c949cd44c1ab334097e15714867
Autor:
Lene Baad-Hansen, Lars Bolvig Hansen, Niels Bang, Helle Wulf Eskildsen, Simple Futarmal Kothari, Peter Svensson, Leif Hovgaard Sørensen
Publikováno v:
Kothari, S F, Baad-Hansen, L, Bolvig, L, Bang, N, Sørensen, L H, Eskildsen, H W & Svensson, P 2016, ' Pain profiling of patients with temporomandibular joint arthralgia and osteoarthritis diagnosed with different imaging techniques ', The Journal of Headache and Pain, vol. 17, no. 1, pp. 61 . https://doi.org/10.1186/s10194-016-0653-6
The Journal of Headache and Pain
The Journal of Headache and Pain
Background Clinical differentiation between pain mechanisms of temporomandibular joint (TMJ) arthralgia and osteoarthritis (OA) is challenging. The aims were to compare somatosensory function at the TMJs and conditioned pain modulation (CPM) effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5541856dc1350e453ab6023a51d69d
https://pure.au.dk/portal/da/publications/pain-profiling-of-patients-with-temporomandibular-joint-arthralgia-and-osteoarthritis-diagnosed-with-different-imaging-techniques(33275d84-af28-4425-9096-43eb59f1cb13).html
https://pure.au.dk/portal/da/publications/pain-profiling-of-patients-with-temporomandibular-joint-arthralgia-and-osteoarthritis-diagnosed-with-different-imaging-techniques(33275d84-af28-4425-9096-43eb59f1cb13).html
Autor:
Steen B, Pedersen, Dorthe, Møller, Jørgen Bendix, Holme, Peter M, Funch-Jensen, Lars Bolvig, Hansen, Hanne, Gammelgaard, Jens F, Bak, Bjørn, Richelsen
Publikováno v:
Ugeskrift for laeger. 167(18)
Publikováno v:
Knee Surgery, Sports Traumatology, Arthroscopy. 7:135-136
Publikováno v:
Acta Psychiatrica Scandinavica. 72:41-50
In an open, prospective 12 month study of perphenazine decanoate (PD), 42 psyhchotic patients diagnosed according to DSM-III were treated with a fixed depot interval and an individual dose, guided by gas chromatographic perphenazine plasma concentrat
Publikováno v:
Acta Psychiatrica Scandinavica. 72:29-40
In an open, prospective 12 month study of perphenazine decanoate (PD), 42 psychotic patients diagnosed according to DSM-III were treated with a fixed depot interval and an individual dose, guided by gas chromatographic perphenazine plasma concentrati
Autor:
Lars Bolvig Hansen, Peder Knudsen, Grete Auken, Karsten Højholdt, Jens Wæhrens, Niels-Erik Larsen
Publikováno v:
Acta Psychiatrica Scandinavica. 72:15-28
In a six-week randomized, double-blind study the efficacy and side effects of perphenazine decanoate (PD) and perphenazine enanthate (PE) were evaluated and compared in 26 and 24 acute psychotic patients respectively. Of either formulation 100 mg wer
Autor:
Niels-Erik Larsen, Lars Bolvig Hansen
Publikováno v:
Nordisk Psykiatrisk Tidsskrift. 40:467-471
A row of analytical methods for determining neuroleptics in blood has been developed with the aim of improving antipsychotic treatment by plasma concentration monitoring. Perphenazine in an optimal therapeutic plasma concentration range between 2 and
Autor:
Lars Bolvig Hansen
Publikováno v:
Nordisk Psykiatrisk Tidsskrift. 34:72-77
En ny serotonin reuptake - inhibitor ZIMELIDIN, undersoges pa endogent deprimerede patienter, udvalgt pa grundlag af Newcastle index I-II.Indtil nu bar 12 patienter gennemfort undersogelsen og indenfor 4-6 uger ar 6 blevet raske, vurderet udfra Cronh
Autor:
Lars Bolvig Hansen, Niels-Erik Larsen
Publikováno v:
Therapeutic Drug Monitoring. 11:642-646
During a 3-month period, 52 paranoid psychotic inpatients were treated with perphenazine decanoate (Trilafon decanoate) in order to determine a treatment schedule ensuring perphenazine serum levels within the optimal range (2-6 nmol/L). All patients